Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas

被引：25
作者：
Sheikhbahaei, Sara [1 ]
Marcus, Charles [1 ]
Hafezi-Nejad, Nima [1 ]
Taghipour, Mehdi [1 ]
Subramaniam, Rathan M. [1 ,2 ,3 ]
机构：
[1] Johns Hopkins Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA
[2] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21231 USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA
来源：
PET CLINICS | 2015年 / 10卷 / 03期
关键词：
Fluorodeoxyglucose; PET; Computed tomography; Patient management; Skeletal sarcoma; Soft tissue sarcoma;
D O I：
10.1016/j.cpet.2015.03.003
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
FDG-PET/CT has been increasingly used in bone and soft tissue sarcomas and provides advantages in the initial tumor staging, tumor grading, therapy assessment, and recurrence detection in these tumors. FDG-PET/CT metabolic parameters are reliable predictors of survival in sarcomas and could be implemented in risk stratification models along with other prognostic factors in these patients.
引用
收藏
页码：375 / 393
页数：19
相关论文
共 144 条
  • [1] GRADING LIPOSARCOMAS WITH PET USING [F-18] FDG
    ADLER, LP
    BLAIR, HF
    WILLIAMS, RP
    PATHRIA, MN
    MAKLEY, JT
    JOYCE, MJ
    ALKAISI, N
    MIRALDI, F
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1990, 14 (06) : 960 - 962
  • [2] Evolving Role of FDG PET/CT in Multiple Myeloma Imaging and Management
    Agarwal, Ankit
    Chirindel, Alin
    Shah, Bhartesh A.
    Subramaniam, Rathan M.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2013, 200 (04) : 884 - 890
  • [3] Antoch G, 2004, J NUCL MED, V45, P357
  • [4] Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients
    Antoniou, Alexander J.
    Marcus, Charles
    Tahari, Abdel K.
    Wahl, Richard L.
    Subramaniam, Rathan M.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (07) : 1062 - 1068
  • [5] FDG-PET in differential diagnosis and grading of chondrosarcomas
    Aoki, J
    Watanabe, H
    Shinozaki, T
    Tokunaga, M
    Inoue, T
    Endo, K
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1999, 23 (04) : 603 - 608
  • [6] Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma
    Arush, M. Weyl Ben
    Israel, O.
    Postovsky, S.
    Militianu, D.
    Meller, I.
    Zaidman, I.
    Sapir, A. Even
    Bar-Shalom, R.
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 49 (07) : 901 - 905
  • [7] Bajpai J, 2011, J PEDIAT HEMATOL ONC, V33, pE271, DOI [10.1097/MPH.0b013e31820ff29e, 10.1097/MPH.0b013e31820ff78e]
  • [8] The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis
    Bastiaannet, E
    Groen, H
    Jager, PL
    Cobben, DCP
    van der Graaf, WTA
    Vaalburg, W
    Hoekstra, HJ
    [J]. CANCER TREATMENT REVIEWS, 2004, 30 (01) : 83 - 101
  • [9] Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors
    Bauer, S.
    Hilger, R. A.
    Muehlenberg, T.
    Grabellus, F.
    Nagarajah, J.
    Hoiczyk, M.
    Reichardt, A.
    Ahrens, M.
    Reichardt, P.
    Grunewald, S.
    Scheulen, M. E.
    Pustowka, A.
    Bock, E.
    Schuler, M.
    Pink, D.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (05) : 1155 - 1162
  • [10] Utilization of positron emission tomography in the management of patients with sarcoma
    Benz, Matthias R.
    Tchekmedyian, Nishan
    Eilber, Fritz C.
    Federman, Noah
    Czernin, Johannes
    Tap, William D.
    [J]. CURRENT OPINION IN ONCOLOGY, 2009, 21 (04) : 345 - 351
12345678910